Cochrane Abstracts
Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mycophenolate Mofetil Versus Methotrexate for Prevention of Graft‐versus‐host Disease in People Receiving Allogeneic Hematopoietic Stem Cell Transplantation." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439289/all/Mycophenolate_mofetil_versus_methotrexate_for_prevention_of_graft‐versus‐host_disease_in_people_receiving_allogeneic_hematopoietic_stem_cell_transplantation.
Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439289/all/Mycophenolate_mofetil_versus_methotrexate_for_prevention_of_graft‐versus‐host_disease_in_people_receiving_allogeneic_hematopoietic_stem_cell_transplantation. Accessed January 13, 2026.
Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439289/all/Mycophenolate_mofetil_versus_methotrexate_for_prevention_of_graft‐versus‐host_disease_in_people_receiving_allogeneic_hematopoietic_stem_cell_transplantation
Mycophenolate Mofetil Versus Methotrexate for Prevention of Graft‐versus‐host Disease in People Receiving Allogeneic Hematopoietic Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439289/all/Mycophenolate_mofetil_versus_methotrexate_for_prevention_of_graft‐versus‐host_disease_in_people_receiving_allogeneic_hematopoietic_stem_cell_transplantation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation
ID - 439289
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439289/all/Mycophenolate_mofetil_versus_methotrexate_for_prevention_of_graft‐versus‐host_disease_in_people_receiving_allogeneic_hematopoietic_stem_cell_transplantation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
